News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,901 Results
Type
Article (41467)
Company Profile (263)
Press Release (690156)
Multimedia
Podcasts (93)
Webinars (20)
Section
Business (204930)
Career Advice (2032)
Deals (35595)
Drug Delivery (130)
Drug Development (81566)
Employer Resources (173)
FDA (16520)
Job Trends (14996)
News (347000)
Policy (32776)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2601)
Accelerated approval (50)
Adcomms (27)
Allergies (171)
Alliances (49596)
ALS (213)
Alzheimer's disease (1805)
Antibody-drug conjugate (ADC) (464)
Approvals (16926)
Artificial intelligence (674)
Autoimmune disease (301)
Automation (56)
Bankruptcy (362)
Best Places to Work (11643)
BIOSECURE Act (20)
Biosimilars (223)
Biotechnology (170)
Bladder cancer (198)
Brain cancer (72)
Breast cancer (766)
Cancer (5912)
Cardiovascular disease (480)
Career advice (1726)
Career pathing (43)
CAR-T (334)
CDC (59)
Celiac Disease (3)
Cell therapy (909)
Cervical cancer (49)
Clinical research (70965)
Collaboration (2082)
Company closure (5)
Compensation (1412)
Complete response letters (80)
COVID-19 (2746)
CRISPR (108)
C-suite (1142)
Cystic fibrosis (152)
Data (8058)
Decentralized trials (3)
Denatured (28)
Depression (162)
Dermatology (90)
Diabetes (591)
Diagnostics (6949)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (330)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (287)
Earnings (92154)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119817)
Executive appointments (1088)
FDA (20288)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1739)
Gene editing (235)
Generative AI (56)
Gene therapy (727)
GLP-1 (1058)
Government (4739)
Grass and pollen (6)
Guidances (408)
Healthcare (19044)
HIV (81)
Huntington's disease (56)
IgA nephropathy (100)
Immunology and inflammation (290)
Immuno-oncology (93)
Indications (196)
Infectious disease (3093)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (293)
Interviews (319)
IPO (16670)
IRA (50)
Job creations (3651)
Job search strategy (1431)
JPM (58)
Kidney cancer (19)
Labor market (102)
Layoffs (566)
Leadership (40)
Legal (7963)
Liver cancer (101)
Longevity (33)
Lung cancer (778)
Lymphoma (433)
Machine learning (60)
Management (59)
Manufacturing (1063)
MASH (191)
Medical device (13945)
Medtech (14075)
Mergers & acquisitions (20189)
Metabolic disorders (1515)
mRNA (212)
Multiple sclerosis (191)
NASH (17)
Neurodegenerative disease (424)
Neuropsychiatric disorders (105)
Neuroscience (3335)
Neurotech (1)
NextGen: Class of 2026 (6526)
Non-profit (4536)
Now hiring (78)
Obesity (707)
Opinion (288)
Ovarian cancer (226)
Pain (258)
Pancreatic cancer (310)
Parkinson's disease (368)
Partnered (33)
Patents (601)
Patient recruitment (681)
Peanut (62)
People (59672)
Pharmaceutical (58)
Pharmacy benefit managers (32)
Phase 1 (22116)
Phase 2 (31274)
Phase 3 (23253)
Pipeline (8964)
Policy (320)
Postmarket research (2569)
Preclinical (9427)
Press Release (64)
Prostate cancer (311)
Psychedelics (54)
Radiopharmaceuticals (327)
Rare diseases (1087)
Real estate (5975)
Recruiting (70)
Regulatory (25475)
Reports (57)
Research institute (2414)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (178)
Series A (289)
Series B (214)
Service/supplier (11)
Sickle cell disease (112)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3643)
State (2)
Stomach cancer (18)
Supply chain (128)
Tariffs (87)
The Weekly (63)
Vaccines (1107)
Venture capital (111)
Weight loss (455)
Women's health (128)
Worklife (20)
Date
Today (152)
Last 7 days (521)
Last 30 days (3421)
Last 365 days (30221)
2026 (13299)
2025 (30184)
2024 (35216)
2023 (40077)
2022 (51188)
2021 (55724)
2020 (54104)
2019 (46573)
2018 (35037)
2017 (32125)
2016 (31502)
2015 (37566)
2014 (31335)
2013 (26364)
2012 (28582)
2011 (29280)
2010 (27351)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (352)
Arkansas (14)
Asia (39723)
Australia (6516)
California (13441)
Canada (3813)
China (1365)
Colorado (569)
Connecticut (580)
Delaware (414)
Europe (86058)
Florida (2010)
Georgia (430)
Hawaii (3)
Idaho (62)
Illinois (1062)
India (91)
Indiana (607)
Iowa (23)
Japan (546)
Kansas (131)
Kentucky (50)
Louisiana (43)
Maine (76)
Maryland (1605)
Massachusetts (9581)
Michigan (369)
Minnesota (726)
Mississippi (6)
Missouri (145)
Montana (33)
Nebraska (29)
Nevada (144)
New Hampshire (84)
New Jersey (3524)
New Mexico (29)
New York (3506)
North Carolina (1699)
North Dakota (9)
Northern California (6755)
Ohio (403)
Oklahoma (23)
Oregon (41)
Pennsylvania (2696)
Puerto Rico (29)
Rhode Island (50)
South America (1112)
South Carolina (86)
South Dakota (2)
Southern California (5305)
Tennessee (214)
Texas (2141)
United States (47339)
Utah (400)
Vermont (1)
Virginia (323)
Washington D.C. (81)
Washington State (1069)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
731,901 Results for "rho inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sharp Therapeutics Corp. Engages Rho Inc. to Help Advance Compounds into Clinical Trials for Gaucher Disease
July 30, 2025
·
5 min read
Press Releases
NEURELIS TO PRESENT STUDY OF NRL-1049, A RHO KINASE (ROCK) INHIBITOR WITH POTENTIAL TO TREAT SYMPTOMATIC CEREBRAL CAVERNOUS MALFORMATIONS (CCM), AT ANNUAL CCM MEETING
November 7, 2025
·
7 min read
Business
Tonix Pharmaceuticals Announces Engagement of Rho as CRO to Support Submission of New Drug Application to the FDA for Approval of Tonmya™ for the Management of Fibromyalgia
Tonix Pharmaceuticals Holding Corp. today announced that it has engaged Rho, Inc. (Rho), a global contract research organization (CRO), to support Tonix’s preparation and planned submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the management of fibromyalgia.
February 13, 2024
·
9 min read
FDA
16 Bit Announces FDA De Novo Marketing Authorization of Rho, an AI-enabled Opportunistic Pre-Screen for Low Bone Mineral Density on Standard X-Rays
16 Bit Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted a De Novo marketing authorization for Rho™, an AI-enabled software device aimed at improving a known care gap in osteoporosis screening.
April 10, 2024
·
2 min read
FDA
Ocugen Announces OCU400 Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Retinitis Pigmentosa Associated with RHO Mutations
Ocugen, Inc. today announced that the FDA has granted RMAT designation to Ocugen’s investigational product OCU400 for the treatment of retinitis pigmentosa (RP) associated with RHO mutations.
December 19, 2023
·
4 min read
Press Releases
Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
May 21, 2026
·
1 min read
Press Releases
Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results
May 8, 2026
·
18 min read
Press Releases
Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026
May 10, 2026
·
2 min read
Press Releases
Stonegate Initiates Coverage on StimCell Energetics Inc. (STME)
May 15, 2026
·
1 min read
Press Releases
RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum
May 20, 2026
·
1 min read
1 of 73,191
Next
